EM
Enumera Molecular, Inc.
SEC filingOther Health Care · Ann Arbor, MI
Amount raised$12.3Msold at filing
Total offering$17.4M$5.1M still open
Investors in the raise12count reported to the SEC
FiledJul 31, 2026first sale Jul 16, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Dan KidleDirector
Matthew CooperExecutive Officer, Director
Elaine HeronDirector
Sundaresh BrahmasandraDirector
Executive officers, directors and promoters as listed on the Form D.